• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性分化型甲状腺癌的当前治疗策略。

Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer.

机构信息

Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Magdeburg, Germany.

Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; and.

出版信息

J Nucl Med. 2019 Jan;60(1):9-15. doi: 10.2967/jnumed.117.190819. Epub 2018 Sep 6.

DOI:10.2967/jnumed.117.190819
PMID:30190306
Abstract

On successful completion of this activity one should be able to judge the prognosis of patients harboring metastasized differentiated thyroid cancer (DTC); identify suitable treatment regimens, taking into account the characteristics of the tumor and the patient's general condition; and know the basics of radioiodine treatment, tyrosine kinase treatment, and redifferentiation treatment for metastasized DTC.

摘要

在成功完成本项学习活动后,医师应该能够对患有转移分化型甲状腺癌(DTC)的患者的预后做出判断;根据肿瘤的特点和患者的一般情况选择合适的治疗方案;了解转移 DTC 的碘治疗、酪氨酸激酶治疗和再分化治疗的基础知识。

相似文献

1
Current Treatment Strategies in Metastasized Differentiated Thyroid Cancer.转移性分化型甲状腺癌的当前治疗策略。
J Nucl Med. 2019 Jan;60(1):9-15. doi: 10.2967/jnumed.117.190819. Epub 2018 Sep 6.
2
Update on recent developments in the therapy of differentiated thyroid cancer.分化型甲状腺癌治疗的最新进展。
Semin Nucl Med. 2010 Mar;40(2):145-52. doi: 10.1053/j.semnuclmed.2009.10.006.
3
Radioiodine refractory differentiated thyroid cancer.放射性碘难治性分化型甲状腺癌。
Crit Rev Oncol Hematol. 2018 May;125:111-120. doi: 10.1016/j.critrevonc.2018.03.012. Epub 2018 Mar 22.
4
Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.放射性碘难治性分化型甲状腺癌的治疗结果及预后因素
Oncologist. 2016 Jan;21(1):50-8. doi: 10.1634/theoncologist.2015-0107. Epub 2015 Dec 16.
5
Differentiated Thyroid Cancer-Treatment: State of the Art.分化型甲状腺癌的治疗:最新进展
Int J Mol Sci. 2017 Jun 17;18(6):1292. doi: 10.3390/ijms18061292.
6
Evolving approaches to patients with advanced differentiated thyroid cancer.进展期分化型甲状腺癌患者治疗方法的演变。
Endocr Rev. 2013 Jun;34(3):439-55. doi: 10.1210/er.2012-1038. Epub 2013 Apr 10.
7
Novel therapeutic options for radioiodine-refractory thyroid cancer: redifferentiation and beyond.放射性碘难治性甲状腺癌的新型治疗选择:再分化及其他。
Curr Opin Oncol. 2020 Jan;32(1):13-19. doi: 10.1097/CCO.0000000000000593.
8
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.放射性碘难治性甲状腺癌的当前治疗标准
Curr Treat Options Oncol. 2016 Jun;17(6):30. doi: 10.1007/s11864-016-0404-6.
9
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E.HER抑制剂促进携带BRAFV600E的乳头状甲状腺癌中BRAF/MEK抑制剂诱导的再分化。
Oncotarget. 2017 Mar 21;8(12):19843-19854. doi: 10.18632/oncotarget.15773.
10
Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.放射性碘难治性分化型甲状腺癌:是时候更新分类了。
Thyroid. 2018 Sep;28(9):1083-1093. doi: 10.1089/thy.2018.0048.

引用本文的文献

1
TSHR in thyroid cancer: bridging biological insights to targeted strategies.甲状腺癌中的促甲状腺激素受体:将生物学见解与靶向策略相联系
Eur Thyroid J. 2025 Jul 3;14(4). doi: 10.1530/ETJ-24-0369. Print 2025 Aug 1.
2
Nomogram Model for Prognosis of Distant Metastatic DTC Based on Inflammatory and Clinicopathological Factors.基于炎症和临床病理因素的远处转移性分化型甲状腺癌预后列线图模型
J Endocr Soc. 2025 Feb 27;9(5):bvaf037. doi: 10.1210/jendso/bvaf037. eCollection 2025 May.
3
Ferroptosis in thyroid cancer: mechanisms, current status, and treatment.
甲状腺癌中的铁死亡:机制、现状与治疗
Front Oncol. 2025 Jan 23;15:1495617. doi: 10.3389/fonc.2025.1495617. eCollection 2025.
4
Role of radiofrequency ablation in the treatment of symptomatic distant metastasis of thyroid cancer.射频消融在甲状腺癌有症状远处转移治疗中的作用。
Skeletal Radiol. 2025 Jan 21. doi: 10.1007/s00256-025-04871-z.
5
Impact of distant metastasis on overall survival and cancer specific survival of elderly patients with differentiated thyroid cancer.远处转移对老年分化型甲状腺癌患者总生存和癌症特异性生存的影响。
Sci Rep. 2024 Oct 22;14(1):24855. doi: 10.1038/s41598-024-76613-5.
6
Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.甲状腺癌中的泛素修饰酶:机制与功能
Heliyon. 2024 Jul 2;10(13):e34032. doi: 10.1016/j.heliyon.2024.e34032. eCollection 2024 Jul 15.
7
Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis.环状 RNA circLIFR 通过调控 miR-429/TIMP2 轴抑制甲状腺乳头状癌细胞的进展。
J Cancer Res Clin Oncol. 2024 Jun 25;150(6):323. doi: 10.1007/s00432-024-05839-7.
8
Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing.利用整合外显子组和转录组测序筛选甲状腺腺癌肿瘤分期特异性候选新抗原。
Front Immunol. 2023 Oct 3;14:1187160. doi: 10.3389/fimmu.2023.1187160. eCollection 2023.
9
Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.基于初始放射性碘治疗反应的儿童和青少年分化型甲状腺癌的长期预后分析。
Front Endocrinol (Lausanne). 2023 Aug 4;14:1217092. doi: 10.3389/fendo.2023.1217092. eCollection 2023.
10
The new insights into autophagy in thyroid cancer progression.甲状腺癌进展中自噬作用的新见解。
J Transl Med. 2023 Jun 24;21(1):413. doi: 10.1186/s12967-023-04265-6.